FSB Premier Wealth Management Inc. Has $854,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

FSB Premier Wealth Management Inc. lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,677 shares of the healthcare conglomerate’s stock after acquiring an additional 49 shares during the period. FSB Premier Wealth Management Inc.’s holdings in UnitedHealth Group were worth $854,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. Macroview Investment Management LLC boosted its stake in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares during the period. Delos Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares during the period. True Wealth Design LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth $31,000. Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group during the second quarter worth about $31,000. Finally, Signature Resources Capital Management LLC increased its holdings in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.5 %

Shares of UNH opened at $598.80 on Wednesday. The stock’s 50-day moving average price is $552.64 and its two-hundred day moving average price is $513.42. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $552.94 billion, a PE ratio of 36.60, a PEG ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $600.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the previous year, the company earned $6.14 EPS. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.67 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.40%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on UNH. Robert W. Baird lifted their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. HSBC boosted their price target on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. JPMorgan Chase & Co. lifted their target price on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Royal Bank of Canada raised their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Finally, Morgan Stanley upped their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average target price of $614.17.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.